Premenstrual Syndromes : PMS and PMDD - Rutuja :: The site ...

Recommendations

Info

Contributors Zenab Amin PhD Department of Psychiatry Yale University School of Medicine New Haven, CT USA Lotta Andréen MD PhD Umeå Neurosteroid Research Center Department of Clinical Sciences Norrland University Hospital Umeå Sweden Torbjörn Bäckström MD PhD Umeå Neurosteroid Research Center Department of Clinical Sciences Norrland University Hospital Umeå Sweden Inger Björn MD PhD Umeå Neurosteroid Research Center Department of Clinical Sciences Norrland University Hospital Umeå Sweden Candace Brown MSN PharmD Professor, Departments of Pharmacy Obstetrics and Gynecology, and Psychiatry University of Tennessee Health Science Center Memphis TN USA Vandana Dhingra MBBS University Hospital of North Staffordshire Keele University Stoke-on-Trent UK C Neill Epperson MD Departments of Psychiatry, Obstetrics Gynecology, and Reproductive Sciences Yale University School of Medicine New Haven, CT USA Elias Eriksson MD Professor of Pharmacology Institute of Neuroscience and Physiology Sahlgrenska Academy Göteborg University Göteborg Sweden Edzard Ernst MD PhD FRCP FRCPEd Complementary Medicine Peninsula Medical School Universities of Exeter and Plymouth Exeter UK Ellen W Freeman PhD Departments of Obstetrics/Gynecology and Psychiatry University of Pennsylvania Philadelphia, PA USA
viii LIST OF CONTRIBUTORS Uriel Halbreich MD Biobehavioral Program State University of New York at Buffalo and WPA Section on Interdisciplinary Collaboration New York, NY USA Khaled MK Ismail MSc MD MRCOG Academic Unit of Obstetrics and Gynecology University Hospital of North Staffordshire UK Inga-Maj Johansson PhD Umeå Neurosteroid Research Center Department of Clinical Sciences Norrland University Hospital Umeå Sweden John Kuo MD Department of Obstetrics and Gynecology David Geffen School of Medicine at UCLA Los Angeles, CA USA Frank W Ling MD Department of Obstetrics and Gynecology Vanderbilt University Women’s Health Specialists, PLLC Germantown, TN USA Magnus Löfgren PhD-Student Umeå Neurosteroid Research Center Department of Clinical Sciences Norrland University Hospital Umeå Sweden Julia L Magnay MSc CSci FIBMS Institute for Science and Technology in Medicine Keele University Stoke-on-Trent UK Graeme F Mason PhD Departments of Psychiatry and Diagnostic Radiology Yale University School of Medicine New Haven, CT USA Kara Lynn McCunn MD Assistant Professor of Psychiatry Yale School of Medicine New Haven, CT USA Judy Mikacich MD Department of Obstetrics and Gynecology David Geffen School of Medicine at UCLA Los Angeles, CA USA PM Shaughn O’Brien MD FRCOG Professor, Women & Children’s Division University Hospital of North Staffordshire Keele University Stoke-on-Trent UK Nick Panay BSc MD FRCOG Consultant Gynaecologist Queen Charlotte’s and Chelsea and Chelsea and Westminster Hospital London UK and Honorary Senior Lecturer Imperial College London UK Teri Pearlstein MD Associate Professor of Psychiatry and Human Behavior Warren Alpert Medical School of Brown University Director, Women’s Behavioral Health and Infants’ Hospital Providence, RI USA Andrea J Rapkin MD Professor of Obstetrics and Gynecology David Geffen School of Medicine at ULCA Los Angeles, CA USA Robert L Reid MD Professor, Obstetrics and Gynecology, Physiology Queen’s University Kingston, Ontario Canada
Page 2: The Premenstrual Syndromes
Page 5 and 6: © 2007 Informa UK Ltd First publis
Page 7: vi CONTENTS 10. Pathophysiology I:
Page 12 and 13: Preface Somatic, affective, and beh
Page 14 and 15: 1 History of the premenstrual disor
Page 16 and 17: and estrogen/progesterone imbalance
Page 18 and 19: Dalton’s PMS, new, more precise t
Page 20 and 21: Many other therapeutic areas have b
Page 22 and 23: 2 The diagnosis of PMS/PMDD - the c
Page 24 and 25: section of gynecological disorders,
Page 26 and 27: Universal acceptance of a diagnosti
Page 28 and 29: Extremely severe Severe None Severi
Page 30 and 31: Table 2.5 Differential diagnosis of
Page 32: 17. Halbreich U, Borenstein J, Pear
Page 35 and 36: 22 THE PREMENSTRUAL SYNDROMES pharm
Page 37 and 38: 24 THE PREMENSTRUAL SYNDROMES IS PM
Page 39 and 40: 26 THE PREMENSTRUAL SYNDROMES 18. S
Page 41 and 42: 28 THE PREMENSTRUAL SYNDROMES METHO
Page 43 and 44: 30 THE PREMENSTRUAL SYNDROMES Table
Page 45 and 46: 32 THE PREMENSTRUAL SYNDROMES DAILY
Page 47 and 48: 34 THE PREMENSTRUAL SYNDROMES Table
Page 49 and 50: 36 THE PREMENSTRUAL SYNDROMES to ot
Page 51 and 52: 38 THE PREMENSTRUAL SYNDROMES prosp
Page 53 and 54: 40 THE PREMENSTRUAL SYNDROMES exami
Page 55 and 56: 42 THE PREMENSTRUAL SYNDROMES healt
Page 57 and 58: 44 THE PREMENSTRUAL SYNDROMES deter
Page 59 and 60:
46 THE PREMENSTRUAL SYNDROMES 35. B
Page 62 and 63:
6 Comorbidity of premenstrual syndr
Page 64 and 65:
inhibitor, medications routinely us
Page 66 and 67:
symptoms as well as worsening of co
Page 68 and 69:
7 The clinical presentation and cou
Page 70 and 71:
ecause ovulation is less frequent a
Page 72 and 73:
to try self-help strategies that ar
Page 74:
40. WHO. International Classificati
Page 77 and 78:
64 THE PREMENSTRUAL SYNDROMES ∆ 4
Page 79 and 80:
66 THE PREMENSTRUAL SYNDROMES Anter
Page 81 and 82:
68 THE PREMENSTRUAL SYNDROMES REFER
Page 83 and 84:
70 THE PREMENSTRUAL SYNDROMES store
Page 85 and 86:
72 THE PREMENSTRUAL SYNDROMES contr
Page 87 and 88:
74 THE PREMENSTRUAL SYNDROMES Serot
Page 89 and 90:
76 THE PREMENSTRUAL SYNDROMES These
Page 91 and 92:
78 THE PREMENSTRUAL SYNDROMES level
Page 93 and 94:
80 THE PREMENSTRUAL SYNDROMES 110.
Page 96 and 97:
10 Pathophysiology I: role of ovari
Page 98 and 99:
different neuromodulatory profile f
Page 100 and 101:
studied, reflecting in part interes
Page 102 and 103:
disturbed in these patients. Compar
Page 104 and 105:
mid-luteal phases of the menstrual
Page 106 and 107:
hyposensitivity or altered circadia
Page 108 and 109:
52. Osterlund MK, Halldin C, Hurd Y
Page 110 and 111:
135. Facchinetti F, Genazzani AD, M
Page 112 and 113:
11 Pathophysiology II: neuroimaging
Page 114 and 115:
orbitofrontal cortex (OFC), and ant
Page 116 and 117:
EVIDENCE OF ALTERED GABAERGIC FUNCT
Page 118 and 119:
the preclinical data indicating tha
Page 120:
19. Nordstrom AL, Olsson H, Halldin
Page 123 and 124:
110 THE PREMENSTRUAL SYNDROMES ster
Page 125 and 126:
112 THE PREMENSTRUAL SYNDROMES ESTR
Page 127 and 128:
114 THE PREMENSTRUAL SYNDROMES tria
Page 129 and 130:
Page 131 and 132:
118 THE PREMENSTRUAL SYNDROMES GABA
Page 133 and 134:
Page 135 and 136:
122 THE PREMENSTRUAL SYNDROMES PERC
Page 137 and 138:
124 THE PREMENSTRUAL SYNDROMES (10
Page 139 and 140:
126 THE PREMENSTRUAL SYNDROMES depr
Page 141 and 142:
128 THE PREMENSTRUAL SYNDROMES and
Page 144 and 145:
15 Psychotropic therapies Meir Stei
Page 146 and 147:
Table 15.2 Intermittent dosing (lut
Page 148 and 149:
Table 15.3 Intermittent vs continuo
Page 150 and 151:
clinical evidence that concomitant
Page 152:
46. Yamada K, Kanba S. Effectivenes
Page 155 and 156:
142 THE PREMENSTRUAL SYNDROMES Tabl
Page 157 and 158:
144 THE PREMENSTRUAL SYNDROMES redu
Page 159 and 160:
146 THE PREMENSTRUAL SYNDROMES PMDD
Page 162 and 163:
17 Clinical evaluation and manageme
Page 164 and 165:
prior to menses) compared with the
Page 166 and 167:
anxiety, or bipolar disorders, post
Page 168 and 169:
premenstrual cognitive disturbance,
Page 170 and 171:
PMS, and bilateral oophorectomy alo
Page 172:
69. Studd J, Leather AT. The need f
Page 175 and 176:
162 THE PREMENSTRUAL SYNDROMES GABA
Page 177 and 178:
164 THE PREMENSTRUAL SYNDROMES the
Page 179 and 180:
166 THE PREMENSTRUAL SYNDROMES psyc
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
172 THE PREMENSTRUAL SYNDROMES In t
Page 187 and 188:
174 THE PREMENSTRUAL SYNDROMES incl
Page 189 and 190:
176 THE PREMENSTRUAL SYNDROMES by g
Page 191 and 192:
178 THE PREMENSTRUAL SYNDROMES REFE
Page 194 and 195:
Index Note to index: PMS is used fo
Page 196 and 197:
levonorgestrol, with estradiol 156
show all

Premenstrual Syndromes : PMS and PMDD - Rutuja :: The site ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?